The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy

Journal:
Blood
Published:
DOI:
10.1182/blood.2024026455
Affiliations:
6
Authors:
35
Go to article
Institutions Authors Share
Erasmus MC Cancer Institute, Netherlands
12.000000
12.000000
 0.34
Amsterdam UMC, Netherlands
9.000000
 0.26
Cancer Center Amsterdam (CCA), Netherlands
9.000000
 0.26
University of Turin (UNITO), Italy
3.000000
 0.09
Erasmus University Medical Center (Erasmus MC), Netherlands
1.000000
 0.03
University Hospital Nantes (CHU de Nantes), France
1.000000
 0.03
Interested in Immunology?